EMITF

Elbit Imaging Ltd. [EMITF] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

EMITF Stock Summary

Top 10 Correlated Stocks

EMITF

In the News

EMITF Financial details

Company Rating
-
Market Cap
10.59M
Income
-490.6M
Revenue
84.36M
Book val./share
-
Cash/share
-
Dividend
0.04
Dividend %
3.91%
Employees
3
Optionable
No
Shortable
Yes
Earnings
-
P/E
-116.14
Forward P/E
-
PEG
-0.51
P/S
-
P/B
0.58
P/C
-
P/FCF
-12.18
Quick Ratio
43.76
Current Ratio
49.23
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-53.3
EPS next Y
-
EPS next Q
-
EPS this Y
-98.48%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-315.38%
-
-
-
-
SMA20
-
SMA50
-0.55%
SMA100
-10%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-0.08%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-3238%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.09561-1.25
52W High
-
52W Low
-
RSI
24.91
Rel Volume
2.91
Avg Volume
86
Volume
250
Perf Week
0%
Perf Month
0%
Perf Quarter
-10%
Perf Half Y
-10%
-
-
-
-
Beta
0.759
-
-
Volatility
0%, 0%
Prev Close
0%
Price
1.8
Change
0%

EMITF Financial Performance

EMITF Dividend History

EMITF Frequently Asked Questions

What is Elbit Imaging Ltd. stock symbol ?

Elbit Imaging Ltd. is a IL stock and trading under the symbol EMITF

What is Elbit Imaging Ltd. stock quote today ?

Elbit Imaging Ltd. stock price is $1.8 today.

Is Elbit Imaging Ltd. stock public?

Yes, Elbit Imaging Ltd. is a publicly traded company.

Something similar

Top by Market Cap
FXAIX
CMC.DE
NVD.DE
ABEC.DE
AMZN
Same Sector
REC.MI
3151.T
RVMD
EMMA
ISRG
Top Correlated Stocks
AKOM.PA
LEBL.PA
MLONL.PA
ALSAF.PA
PMVC
Similar Market Cap
BRES.L
FRUC.L
SSTY.L
ALNRG.PA
WTDQ.DE

Company Profile

Healthcare Medical - Devices
  • Volume Average 86
  • Market Capitalization 10.59M
  • Employee 3
  • CEO Mr. Ron Hadassi BA, LL.B, MBA
  • Headquarters Petah Tikva,IL
  • IPO Date 1996-11-27

Elbit Imaging Ltd., together with its subsidiaries, engages in the development, production, and marketing of therapeutic medical systems for performing non-invasive treatments on the human body in the North and South America, Europe, Asia, and Oceania. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was incorporated in 1996 and is headquartered in Petach Tikva, Israel.